Where can I buy dabrafenib?

Dabrafenib (Dabrafenib) is a new generation of targeted therapy, mainly used to treat patients with BRAF V600E or V600K gene mutation malignant melanoma (MM) and non-small cell lung cancer (NSCLC). The development of this drug marks an important advancement in the field of cancer treatment, providing some patients with more personalized and effective treatment options.

Dabrafenib is already on the market in China and has been included in medical insurance. Patients can buy it domestically. The price is about 10,000 yuan in China. The price is still relatively expensive. Please consult the local hospital pharmacy for specific prices. Dabrafenib, which is relatively cheap abroad, is mainly a generic drug, mainly a Laotian generic drug. The price is about two to three thousand yuan, which is much cheaper than domestic drugs. The ingredients of foreign generic drugs and domestic original drugs are basically the same.

The mechanism of action of dabrafenib mainly focuses on the inhibition ofBRAFkinase. BRAFgene mutations play an important role in a variety of cancers, promoting the growth and spread of tumor cells by overactivating the BRAFkinase. Dabrafenib selectively inhibits the activity of BRAF kinase and effectively blocks the abnormal activation of the RAS/RAF/MEK/ERK signaling pathway, thus limiting the proliferation of cancer cells.

In therapeutic practice, dabrafenib is often combined withMEK inhibitors to improve efficacy and reduce the risk of drug resistance. This combination therapy has shown significant efficacy in clinical trials, bringing new hope to patients with malignant melanoma.

However, patients need to pay close attention to possible side effects when using dabrafenib, including fever, skin reactions, fatigue, etc. Professional doctors will monitor and adjust during the treatment process to ensure that patients can benefit from the treatment to the greatest extent.